Navitas Life Sciences

Shafiq is the CEO of Navitas Life Sciences. To contact Shafiq email at [email protected] or [email protected].

The decision makers in Navitas Life Sciences are Shafiq, Mallikaarjunan R, Manju Thomas, etc. Click to Find Navitas Life Sciences decision makers emails.

Navitas Life Sciences offers a comprehensive range of clinical trial services, including full-service clinical trials across all phases (Phase 1 to Phase 4). We specialize in various areas such as non-interventional studies, risk-based monitoring, and virtual clinical trials. Our expertise extends to biosimilars and we provide end-to-end labeling services to ensure compliance and accuracy throughout the trial process.

At Navitas Life Sciences, we prioritize data integrity and compliance through robust data management and biostatistics practices. Our risk-based monitoring approach allows us to identify and mitigate potential issues proactively. Additionally, we adhere to rigorous regulatory standards and guidelines, ensuring that all data collected during trials is accurate, reliable, and compliant with industry regulations.

Regulatory consulting at Navitas Life Sciences involves providing expert guidance on regulatory submissions and lifecycle management. Our team assists clients in navigating complex regulatory environments, ensuring that their products meet all necessary requirements for approval. This includes support for biosimilars, where we help clients understand the specific regulatory pathways and documentation needed for successful submission.

Yes, Navitas Life Sciences offers comprehensive pharmacovigilance (PV) services. Our PV consulting includes monitoring and managing the safety of pharmaceutical products throughout their lifecycle. We provide solutions for adverse event reporting, risk assessment, and compliance with regulatory requirements, ensuring that our clients maintain the highest standards of patient safety.

Navitas Life Sciences serves a diverse range of industries within the life sciences sector, including pharmaceuticals, biotechnology, and medical devices. Our expertise allows us to support clients across various therapeutic areas, providing tailored solutions that meet the unique challenges of each industry. We are committed to advancing healthcare through innovative research and development.

Navitas Life Sciences embraces the future of clinical research with our virtual clinical trials approach. We leverage technology to enhance patient engagement and streamline data collection, allowing for remote participation in trials. This model increases accessibility for patients and can lead to faster recruitment and retention rates, ultimately accelerating the development of new therapies while maintaining rigorous scientific standards.